EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).
- Website
- Get directions
- Bookmark
- Share
- Report
- prev
- next
Location
-
Seestrasse 352, 8038 Zürich, Switzerland
Additional address info
- c/o ABT Treuhandgesellschaft AG
Canton
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2022
-
Number of employees in Switzerland1-9
Core competencies
You may also be interested in
Ironwood Pharmaceuticals GmbH 
- R&D
Member
Renaldee AG
- R&D
Member
HekeTiss SA
- Production (of own products), R&D
Member